These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1431162)

  • 1. Direct visualisation and quantification of cellular cytotoxicity using two colour flourescence.
    Kroesen BJ; Mesander G; ter Haar JG; The TH; de Leij L
    J Immunol Methods; 1992 Nov; 156(1):47-54. PubMed ID: 1431162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rapid and sensitive fluorometric microassay for determining cell mediated cytotoxicity to adherent growing cell lines.
    Krüger-Krasagakes S; Garbe C; Kossman P; Orfanos CE
    J Immunol Methods; 1992 Nov; 156(1):1-8. PubMed ID: 1431156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of human natural killer and lymphokine-activated killer cell cytotoxicity against Toxoplasma gondii trophozoites and brain cysts.
    Dannemann BR; Morris VA; Araujo FG; Remington JS
    J Immunol; 1989 Oct; 143(8):2684-91. PubMed ID: 2477453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel method for the simultaneous assessment of natural killer cell conjugate formation and cytotoxicity at the single-cell level by multi-parameter flow cytometry.
    Godoy-Ramirez K; Franck K; Gaines H
    J Immunol Methods; 2000 May; 239(1-2):35-44. PubMed ID: 10821945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of effector/target conjugation involving natural killer (NK) or lymphokine activated killer (LAK) cells by two-color flow cytometry.
    Radcliff G; Waite R; LeFevre J; Poulik MD; Callewaert DM
    J Immunol Methods; 1991 Jun; 139(2):281-92. PubMed ID: 2045664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LAK-cell-mediated cytotoxicity against tumor cell targets used to monitor the stimulatory effect of interleukin-2: cytotoxicity, target recognition and phenotype of effector cells lysing the Daudi, T24 and K562 tumor cell lines.
    Hermann GG; Zeuthen J; Claësson MH
    Nat Immun; 1992; 11(1):7-16. PubMed ID: 1611282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of europium and chromium release assays: cytotoxicity in healthy individuals and patients with cervical carcinoma.
    von Zons P; Crowley-Nowick P; Friberg D; Bell M; Koldovsky U; Whiteside TL
    Clin Diagn Lab Immunol; 1997 Mar; 4(2):202-7. PubMed ID: 9067656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of fluorochrome-labeled and 51Cr-labeled targets for natural killer cytotoxicity assay.
    Wierda WG; Mehr DS; Kim YB
    J Immunol Methods; 1989 Aug; 122(1):15-24. PubMed ID: 2760476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay.
    Kim GG; Donnenberg VS; Donnenberg AD; Gooding W; Whiteside TL
    J Immunol Methods; 2007 Aug; 325(1-2):51-66. PubMed ID: 17617419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An improved fluorescence assay for the determination of lymphocyte-mediated cytotoxicity using flow cytometry.
    Papadopoulos NG; Dedoussis GV; Spanakos G; Gritzapis AD; Baxevanis CN; Papamichail M
    J Immunol Methods; 1994 Dec; 177(1-2):101-11. PubMed ID: 7822816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of elevated temperature on natural killer cell activity, lymphokine-activated killer cell activity and lectin-dependent cytotoxicity of human umbilical cord blood and adult blood cells.
    Shen RN; Lu L; Young P; Shidnia H; Hornback NB; Broxmeyer HE
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):821-6. PubMed ID: 8040029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel cytolysis assay using fluorescent labeling and quantitative fluorescent scanning technology.
    Roden MM; Lee KH; Panelli MC; Marincola FM
    J Immunol Methods; 1999 Jun; 226(1-2):29-41. PubMed ID: 10410969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human tumor cell line resistance to chemotherapeutic agents does not predict resistance to natural killer or lymphokine-activated killer cell-mediated cytolysis.
    Harker WG; Tom C; McGregor JR; Slade L; Samlowski WE
    Cancer Res; 1990 Sep; 50(18):5931-6. PubMed ID: 1975512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human pulmonary natural killer (NK) cells exhibit limited lymphokine-activated killer (LAK) activity.
    Yarbrough WC; Weissler JC
    Am J Respir Cell Mol Biol; 1989 Oct; 1(4):305-11. PubMed ID: 2483121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphokine-activated killer cell activity after cryopreservation.
    Schmidt-Wolf IG; Aihara M; Negrin RS; Blume KG; Chao NJ
    J Immunol Methods; 1989 Dec; 125(1-2):185-9. PubMed ID: 2607152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of B16 melanoma sublines to lymphokine-activated killer cells as determined by 51Cr-release and clonogenic assays.
    Tzeng JJ; Barth RF
    J Immunol Methods; 1990 Apr; 128(2):257-66. PubMed ID: 2324514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells.
    Shresta S; MacIvor DM; Heusel JW; Russell JH; Ley TJ
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5679-83. PubMed ID: 7777569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fluorescence-based assay for quantitation of lymphokine-activated killer cell activity.
    Volgmann T; Klein-Struckmeier A; Mohr H
    J Immunol Methods; 1989 Apr; 119(1):45-51. PubMed ID: 2785144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between multi-drug resistance and resistance to natural-killer-cell and lymphokine-activated killer-cell lysis in human leukemic cell lines.
    Treichel RS; Olken S
    Int J Cancer; 1992 Jan; 50(2):305-10. PubMed ID: 1370437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.